ITEMS IN AFP WITH KEYWORD:

Hepatitis

Sep 15, 2020 Issue
Screening for Hepatitis C Virus Infection in Adolescents and Adults: Recommendation Statement [U.S. Preventive Services Task Force]

The USPSTF recommends screening for hepatitis C virus infection in adults aged 18 to 79 years.


Sep 15, 2020 Issue
Screening for Hepatitis C Virus Infection in Adolescents and Adults [Putting Prevention into Practice]

M.S. is a 20-year-old man who presents for a preemployment physical examination. He states that he is single, has two or three drinks per month on social occasions, does not smoke, is sexually active, and does not use illicit drugs.


Jan 1, 2020 Issue
Branched-chain Amino Acids for Patients with Hepatic Encephalopathy [Medicine by the Numbers]

Hepatic encephalopathy is a brain dysfunction that can be mild with minimal confusion, or overt and severe with coma. Learn more about branched-chain amino acids for the treatment of hepatic encephalopathy.


Aug 15, 2019 Issue
Treating Hepatitis C in the Family Medicine Office [Close-ups]

Patient story about being diagnosed with hepatitis C and successful treatment by family doctor.


Mar 1, 2019 Issue
Hepatitis B: Screening, Prevention, Diagnosis, and Treatment [Article]

Screening for hepatitis B is recommended in pregnant women at their first prenatal visit and in adolescents and adults at high risk of chronic infection. Individualized treatment plans should take into account clinical and laboratory characteristics and risk of cirrhosis and hepatocellular carcinoma. Peginterferon alfa-2a, entecavir, and tenofovir are considered first-line treatment options. Vaccination is recommended for appropriate patients.


Nov 15, 2018 Issue
Glecaprevir/Pibrentasvir (Mavyret) for the Treatment of Chronic Hepatitis C [STEPS]

Glecaprevir/pibrentasvir is an effective treatment for any of six genotypes of HCV infection and has few adverse effects. It can be used to treat more genotypes over a shorter duration (eight weeks for patients without cirrhosis) and is substantially less expensive than other available treatments.


Oct 1, 2018 Issue
Family Physicians Can Manage Adults with Hepatitis C [Editorials]

The Centers for Disease Control and Prevention encourages family physicians to treat patients with hepatitis C. Outcomes when primary care physicians prescribe direct-acting antivirals to patients with uncomplicated hepatitis C are comparable to those of subspecialists.


Jul 15, 2018 Issue
Hepatitis B Virus Vaccination and Screening: Best Practices from the ACP and CDC [Practice Guidelines]

The American College of Physicians and Centers for Disease Control and Prevention highlights the consensus among these recommendations, with recent evidence, to develop a best practice advice statement for vaccination, screening, care, and treatment of patients at risk of or who currently have HBV infection.


Jun 1, 2017 Issue
Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C [Medicine by the Numbers]

Although they help patients achieve sustained viralogic response, expensive direct-acting antivirals have yet to show that they can succeed in meeting top-priority treatment goals.


May 15, 2017 Issue
Sofosbuvir/Velpatasvir (Epclusa) for Hepatitis C [STEPS]

Sofosbuvir/velpatasvir is an effective treatment for patients with HCV and has minimal adverse effects. It is the preferred treatment for patients with genotype 2 or 3. As with other curative treatments, it is very expensive.


Pages: 1 2 3 4 5 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now